The Art and Politics of Science

The Art and Politics of Science

by Harold Varmus

Hardcover

$20.95 $24.95 Save 16% Current price is $20.95, Original price is $24.95. You Save 16%.
View All Available Formats & Editions

Overview

A Nobel Prize–winning cancer biologist, leader of major scientific institutions, and scientific adviser to President Obama reflects on his remarkable career.


A PhD candidate in English literature at Harvard University, Harold Varmus discovered he was drawn instead to medicine and eventually found himself at the forefront of cancer research at the University of California, San Francisco. In this “timely memoir of a remarkable career” (American Scientist), Varmus considers a life’s work that thus far includes not only the groundbreaking research that won him a Nobel Prize but also six years as the director of the National Institutes of Health; his current position as the president of the Memorial Sloan-Kettering Cancer Center; and his important, continuing work as scientific adviser to President Obama. From this truly unique perspective, Varmus shares his experiences from the trenches of politicized battlegrounds ranging from budget fights to stem cell research, global health to science publishing.

Product Details

ISBN-13: 9780393061284
Publisher: Norton, W. W. & Company, Inc.
Publication date: 02/02/2009
Pages: 256
Product dimensions: 6.50(w) x 9.20(h) x 1.30(d)

About the Author

Harold Varmus, director of the National Cancer Institute and president of Memorial Sloan-Kettering Cancer Center, lives with his wife, Constance Casey, and their two sons in New York City.

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews

The Art and Politics of Science 4.3 out of 5 based on 0 ratings. 6 reviews.
prima1 on LibraryThing More than 1 year ago
This was a very disappointing experience. First, Varmus goes in my opinion too fast through his early days from medical student to postdoctoral fellow in Pastan's lab. Second, one of the most interesting aspects of Varmus career is his collaboration with M. Bishop. He delays describing why they separated but it is obvious that there were other issues not mentioned here. The relationship between mentor-student is a difficult one and more insight will be of importance. At least Varmus mentions it. Bishop did not in his own biography a few years back. Finally, the experience at the NIH is too superficial and focused on not very important details such as how long it took to get confirmed. It would have been interesting to learn about Clinton and Gore etc...Finally there is no mention about his years at MSKCC.In summary, this book is really too politically correct and superficial. It is a shame because Dr. Varmus is a great leader in his field
Anonymous More than 1 year ago
TheCurtain More than 1 year ago
for a summary of ethics and safety concerns at a high profile cancer research center (mskcc), where clinical trial candidates are developed, please see: www.mskccheats.blogspot.com "Sloan is pursuing a systemic approach to reducing expenses and increasing revenues [.] One example of this is discouraging terminally ill patients from seeking initial treatment or second opinions from the cancer center [.] the admission of such patients is counterproductive [.] to Sloan Kettering." [paraphrasing salient features, MSKCC, CFO/Chief Financial Officer] MSKCC, we hoped you'd be our hero. Minimally, MSKCC, you're SUPPOSED to care.
ManBehindTheCurtain More than 1 year ago
for a summary of ethics and safety concerns at a high profile cancer research center (mskcc) please see: http://www.mskccheats.blogspot.com in addition to the art and politics of science there is disingenuous and greed MSKCCheats: "Sloan is pursuing a systemic approach to reducing expenses and increasing revenues [.] One example of this is discouraging terminally ill patients from seeking initial treatment or second opinions from the cancer center [.] the admission of such patients is counterproductive [.] to Sloan Kettering." [paraphrasing salient features, MSKCC, CFO/Chief Financial Officer]
Anonymous More than 1 year ago
for a summary of ethics and safety concerns at a high profile cancer center (mskcc), please see: http://www.mskccheats.blogspot.com "Sloan is pursuing a systemic approach to reducing expenses and increasing revenues [.] One example of this is discouraging terminally ill patients from seeking initial treatment or second opinions from the cancer center [.] the admission of such patients is counterproductive [.] to Sloan Kettering." [paraphrasing salient features, MSKCC, CFO/Chief Financial Officer]
InsincereScience More than 1 year ago
"Sloan is pursuing a systemic approach to reducing expenses and increasing revenues [.] One example of this is discouraging terminally ill patients from seeking initial treatment or second opinions from the cancer center [.] the admission of such patients is counterproductive [.] to Sloan Kettering." [paraphrasing salient features, MSKCC, CFO/Chief Financial Officer]. lovely.